Corbus Pharmaceuticals Holdings (CRBP) Operating Leases (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Operating Leases of $307000.0 for Q3 2025, down 85.01% year-over-year from $2.0 million in Q3 2024, and down 59.66% quarter-over-quarter from $761000.0 in Q2 2025.
Corbus Pharmaceuticals Holdings (CRBP) Operating Leases (2018 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Operating Leases history runs 8 years deep, the most recent figure standing at $307000.0 for Q3 2025.
- In Q3 2025, Operating Leases fell 85.01% year-over-year to $307000.0; the TTM figure through Sep 2025 stood at $307000.0 (down 85.01% YoY), while the FY2024 annual figure was $1.6 million, down 49.58% from the prior year.
- Operating Leases for Q3 2025 stood at $307000.0, down from $761000.0 in the prior quarter.
- The five-year high for Operating Leases was $7.9 million in Q1 2021, with the low at $307000.0 in Q3 2025.
- The 5-year median for Operating Leases is $4.0 million (2023), against an average of $3.9 million.
- The sharpest annual moves came in 2021 and 2025: Operating Leases retreated 8.64% in 2021, then slumped 85.01% in 2025.
- Corbus Pharmaceuticals Holdings' Operating Leases stood at $6.0 million in 2021, then fell by 21.5% to $4.7 million in 2022, then plunged by 30.72% to $3.2 million in 2023, then slumped by 49.58% to $1.6 million in 2024, then plunged by 81.2% to $307000.0 in 2025.
- Business Quant data shows CRBP's Operating Leases at $307000.0 in Q3 2025, $761000.0 in Q2 2025, and $1.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 127.01 Mn | -36.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 307,000.00 |
| Jun 30, 2025 | 761,000.00 |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 2.86 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | 3.61 Mn |
| Jun 30, 2023 | 3.98 Mn |
| Mar 31, 2023 | 4.33 Mn |
| Dec 31, 2022 | 4.68 Mn |
| Sep 30, 2022 | 5.01 Mn |
| Jun 30, 2022 | 5.33 Mn |
| Mar 31, 2022 | 5.65 Mn |
| Dec 31, 2021 | 5.96 Mn |
| Sep 30, 2021 | 6.25 Mn |
| Jun 30, 2021 | 7.61 Mn |
| Mar 31, 2021 | 7.86 Mn |
| Dec 31, 2020 | 7.09 Mn |